Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0OC6H
|
||||
Former ID |
DIB011692
|
||||
Drug Name |
S-024
|
||||
Synonyms |
Chk1 inhibitors (cancer); S-024; S-144; Chk1 inhibitors (cancer), Sentinel
|
||||
Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Investigative | [543531] | ||
Company |
Sentinel Oncology Ltd
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
C[N+](C)(CCCOc1c(NC(=O)Nc2cnc(cn2)C#N)cc(cc1)Cl)[O-]
|
||||
Target and Pathway | |||||
Target(s) | Serine/threonine-protein kinase Chk1 | Target Info | Inhibitor | [543531] | |
Pathway Interaction Database | Fanconi anemia pathway | ||||
p73 transcription factor network | |||||
ATR signaling pathway | |||||
Circadian rhythm pathway | |||||
p53 pathway | |||||
Reactome | Activation of ATR in response to replication stress | ||||
Processing of DNA double-strand break ends | |||||
Presynaptic phase of homologous DNA pairing and strand exchange | |||||
G2/M DNA damage checkpoint | |||||
Ubiquitin Mediated Degradation of Phosphorylated Cdc25A | |||||
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.